Predoctoral researcher Anna Adam, who received the help of the Spanish Association Against Cancer (AECC) in Valencia to develop her doctoral thesis, has achieved a new advance in improving the early diagnosis of breast cancer.
One of the great advantages that can be had when treating cancer successfully is finding it when it is still in the initial stages of its development (early diagnosis). In this regard, mammograms have made it possible to improve the survival of cancer patients, however, non-invasive techniques such as liquid biopsy can help improve the diagnosis by complementing mammograms. Using liquid biopsy, INCLIVA researchers have observed that in breast cancer patients they find higher levels of a microscopic molecule in the blood plasma than in healthy patients, called miR-30b-5p microRNA. Furthermore, the levels were higher in patients with lymph nodes in the armpit and with initial metastases. Therefore, finding high levels of these molecules in the blood can work as a good tool for the early detection of breast cancer with risk of metastasis. A less invasive, fast and low-cost complementary method to mammograms that could help improve patient survival.
–
